Full text is available at the source.
Effects of glucagon-like peptide-1 receptor agonists on gastric mucosal visibility and retained gastric contents during EGD
How diabetes drugs affect stomach lining visibility and leftover stomach contents during endoscopy
AI simplified
Abstract
GLP-1RA users had a 2.42 times higher likelihood of lower gastric mucosal visibility scores during endoscopy.
- A total of 168 individuals were analyzed in a matched case-control study.
- Users of GLP-1 receptor agonists showed significantly lower visibility scores compared to nonusers.
- The incidence of retained gastric contents was higher in GLP-1RA users at 13.1% versus 4.8% in nonusers.
- GLP-1RA users had an adjusted odds ratio of 4.62 for experiencing retained gastric contents.
- Procedures were more likely to be aborted in GLP-1RA users due to retained contents.
- No anesthesia-related adverse events were reported in either group.
AI simplified